Abstract
Stem cell therapy has emerged as a promising avenue for regenerative medicine, offering the potential to treat a wide range of debilitating diseases and injuries. Among the various types of stem cells, mesenchymal stem cells (MSCs) have garnered significant attention due to their unique properties and therapeutic potential. In recent years, researchers have been exploring novel approaches to enhance the effectiveness of MSC-based therapies. One such approach that has gained traction is the priming of MSCs with molecular hydrogen (H2). This article delves into the fascinating world of mesenchymal stem cell priming with molecular hydrogen and the potential benefits it holds for regenerative medicine.
Author supplied keywords
Cite
CITATION STYLE
Artamonov, M. Y., LeBaron, T. W., Pyatakovich, F. A., & Minenko, I. A. (2024, April 1). Mesenchymal Stem Cell Priming: Potential Benefits of Administration of Molecular Hydrogen. Pharmaceuticals. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/ph17040469
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.